KANGHUI PHARMACEUTICAL released its first-quarter performance, reporting a net loss attributable to the parent of 17.2393 million yuan, turning from profit to loss
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, KANGHUI PHARMACEUTICAL (603139.SH) released its first-quarter report for 2025. The company's first-quarter operating revenue was 121 million yuan, a year-on-year decrease of 4.72%; the net loss attributable to shareholders of the listed company was 17.2393 million yuan, turning from profit to loss; the net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 18.4152 million yuan, with losses widening; the basic loss per share was 0.17 yuan/share
